Alli and Xenical are two U.S. orlistat brands with different retail identities and access requirements. Alli contains orlistat 60 mg and is sold over the counter for eligible adults under its Drug Facts label. Xenical contains orlistat 120 mg and is a prescription product with clinician-directed labeling. Both affect digestion of dietary fat by inhibiting gastrointestinal lipases, but the brands should not be treated as interchangeable purchases simply because they share an ingredient.
A useful Alli vs Xenical comparison covers more than capsule strength. Shoppers need to understand the product they will receive, the role of the OTC package versus the prescription pharmacy label, whether a clinician is required, the relevant population and how final cost is determined. The Alli brand profile and the Xenical brand profile describe the products individually; this page compares the choices side by side.
Neither brand is a guaranteed weight-loss result, and neither should be selected solely on an advertised price or a claim that “stronger” automatically means “better” for a particular person. The current labels contain warnings involving gastrointestinal symptoms, medications, vitamin absorption and rare kidney injury. OrliLab is an independent affiliate-supported educational site, not a pharmacy or prescriber; selection and treatment decisions should account for the actual label and medical circumstances.
The clearest separation is retail and regulatory: Alli is an OTC branded orlistat product while Xenical is the prescription branded version. For a shopper, that changes what documentation is needed, who can dispense the product and what information accompanies the purchase. The comparison should stay anchored to FDA-labeled products on the U.S. market rather than product names used by overseas sellers.
These brand distinctions do not establish current stock in a specific store. A listing for the ingredient alone may refer to a different product. Use a product-specific check before ordering.
| Characteristic | Alli | Xenical |
|---|---|---|
| Active ingredient | Orlistat | Orlistat |
| U.S. brand strength | 60 mg capsules | 120 mg capsules |
| Access | OTC; no prescription for labeled purchase | Prescription required |
| Main commercial route | Retail or legitimate OTC online seller | Licensed prescription pharmacy |
| Labeled population | Overweight adults 18+ under OTC Drug Facts | Obesity management under clinician evaluation; labeling includes evidence in ages 12–16 |
| Treatment framework | OTC weight-loss aid with reduced-calorie, low-fat diet | Rx obesity treatment including weight-loss maintenance and weight-regain risk reduction |
| Payment context | Usually compared by OTC package total | Brand Rx quote, insurance and cash options |
Alli’s OTC Drug Facts labeling describes a weight-loss aid for overweight adults aged 18 and older in conjunction with a reduced-calorie, low-fat diet. Xenical’s prescription labeling addresses obesity management, weight-loss maintenance and reduction of weight regain under defined clinical conditions; it also includes pediatric safety and efficacy data for obese adolescents aged 12–16. That does not make Xenical an OTC option for minors or create a recommendation to use it without medical evaluation.
Do not extrapolate Alli’s OTC directions to Xenical or assume that a Xenical prescription gives independent permission to improvise with OTC capsules. Orlistat access classification details the OTC and Rx boundary; the age and medical questions should be checked against the actual current product label.
An Alli purchase is typically evaluated through a sealed retail package with an OTC Drug Facts panel, strength, directions, warnings, capsule count and expiration information. A Xenical prescription transaction should be linked to the dispensed product and an individual pharmacy label, with counseling and product information as required by the dispensing process.
Brand imagery alone does not prove authenticity, especially on third-party marketplaces. Buyers should check product name, strength, lawful seller and source of the dispensed medicine. Online safety explains warning signs of misleading listings; this comparison stays focused on real brand identities.
For Alli, a consumer should confirm the proper OTC product, labeling and legitimate retailer. A checkout page should not imply that a prescription is necessary simply to purchase labeled OTC Alli, although clinical advice may be appropriate for medical concerns. For Xenical, a licensed clinician must prescribe when appropriate, and a licensed pharmacy must handle the dispensing process.
A telehealth evaluation, when legally and clinically appropriate, may be one route to a prescription; it is not a guaranteed checkout shortcut. Buying Alli and obtaining Xenical provide separate transaction-focused workflows.
Alli is commonly compared by the total retail cost of a specific OTC package and any eligible retailer promotion. Xenical is compared as a prescription brand by current pharmacy cash price, applicable insurance rules and brand-versus-generic alternatives. A discount shown for one brand should not be assumed to apply to the other.
For a meaningful comparison, identify the product and supply quantity, then request current quotes from legitimate sellers. Alli price factors and Xenical price factors offer brand-specific cost analysis, keeping this comparison concise.
The phrase “Alli versus Xenical” excludes an important third category: prescription generic orlistat 120 mg. U.S. labeling records include authorized generic prescription orlistat, but that does not prove a product is in stock locally or that every website selling “generic Xenical” has a legitimate U.S. product.
A buyer evaluating a Xenical prescription may ask the pharmacist whether an appropriate generic can be dispensed under applicable substitution rules. The generic orlistat guide owns the different product identities and regulatory concepts; this page simply shows where they belong alongside the brands.
Orlistat products can produce oily stools, gas with discharge, bowel urgency and related gastrointestinal effects, especially when dietary fat intake is high. Orlistat can interfere with absorption of fat-soluble vitamins and may interact with medicines. Product warnings also address relevant conditions such as malabsorption and kidney risk. A familiar OTC brand name does not erase these warnings.
The FDA updated OTC Alli warnings in June 2026 to address rare acute kidney injury and kidney-stone concerns consistently with prescription orlistat labeling. Side effects and kidney-related warnings provide focused information for discussion with a healthcare professional.
When comparing the brands as potential purchases, check the actual carton or pharmacy label, prescription requirement, intended patient population, applicable warnings, and whether a generic 120 mg product is an option. Separate those practical differences from the question of how 60 mg and 120 mg performed in clinical studies: the two numbers alone cannot establish a personal outcome or treatment choice.
For a closer look at numerical strength and what clinical evidence can and cannot show, consult the 120 mg versus 60 mg comparison. For brand selection, the starting point remains the appropriate U.S. label, lawful access and professional guidance where needed.
Identify which product and strength are being considered, verify whether a prescription is required, assess the current U.S. labeling, check the expected pharmacy or retail channel and compare product-specific total costs. A useful choice starts with suitability, not an online claim that one brand produces automatic results.
If the shopper has kidney disease history, other medications, pregnancy or malabsorption concerns, appropriate professional review should precede purchasing. Contraindications explains major restrictions; individual treatment decisions cannot be made from a consumer comparison chart.
OrliLab may link to affiliated merchants or services, but referral compensation does not establish that a particular seller has genuine Alli or Xenical ready to dispense. Advertised prices, packaging, availability and permitted fulfillment channels can change.
The comparison is designed to help a reader ask the right questions of a legitimate U.S. seller or licensed clinician. It is not a prescription recommendation, a live retail inventory display or a substitute for the current U.S. product labeling.
They contain the same active ingredient, orlistat, but are different U.S. branded products with different strengths and OTC versus prescription access.
Alli 60 mg is sold over the counter in the United States under its Drug Facts labeling for eligible adults.
Yes. Xenical 120 mg is a prescription medicine and must be dispensed through a lawful prescription pathway.
No. Xenical contains 120 mg of the same active ingredient per capsule, but it is a prescription product with different labeling, clinical oversight and indications. Doubling the strength does not establish a proportional weight-loss effect.
Do not improvise a substitution. OTC and prescription products have different labeling, and any regimen or substitution decision belongs to a healthcare professional.
Yes. Both contain orlistat, which inhibits gastrointestinal lipases and reduces absorption of some dietary fat.
There is no universal answer. Compare a specific OTC package against a prescription product using current legitimate quotes and relevant payment rules.
U.S. records document prescription generic orlistat products, including an authorized generic, but current pharmacy availability must be verified.
No. OTC status does not remove adverse effects, interaction risks or warnings, including kidney concerns.
There is no universal winner. Alli is an OTC option under adult-use labeling, while Xenical requires a prescription and clinician evaluation. The appropriate choice depends on the actual indication, medical history, interactions and product labeling—not just brand name or price.